Mesenchymal stem cell‐based treatments for stroke, neural trauma, and heat stroke

Brain and Behavior - Tập 6 Số 10 - 2016
Yogi Hsuan1, Cheng‐Hsien Lin1, Ching‐Ping Chang2, Mao‐Tsun Lin2
1Meridigen Biotech CO., Ltd. Neihu Taipei Taiwan
2Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan

Tóm tắt

AbstractBackground

Mesenchymal stem cell (MSC) transplantation has been reported to improve neurological function following neural injury. Many physiological and molecular mechanisms involving MSC therapy‐related neuroprotection have been identified.

Methods

A review is presented of articles that pertain to MSC therapy and diverse brain injuries including stroke, neural trauma, and heat stroke, which were identified using an electronic search (e.g., PubMed), emphasize mechanisms of MSC therapy‐related neuroprotection. We aim to discuss neuroprotective mechanisms that underlie the beneficial effects of MSCs in treating stroke, neural trauma, and heatstroke.

Results

MSC therapy is promising as a means of augmenting brain repair. Cell incorporation into the injured tissue is not a prerequisite for the beneficial effects exerted by MSCs. Paracrine signaling is believed to be the most important mediator of MSC therapy in brain injury. The multiple mechanisms of action of MSCs include enhanced angiogenesis and neurogenesis, immunomodulation, and anti‐inflammatory effects. Microglia are the first source of the inflammatory cascade during brain injury. Cytokines, including tumor necrosis factor‐α, interleukin‐1β, and interleukin‐6, are significantly produced by microglia in the brain after experimental brain injury. The proinflammatory M1 phenotype of microglia is associated with tissue destruction, whereas the anti‐inflammatory M2 phenotype of microglia facilitates repair and regeneration. MSC therapy may improve outcomes of ischemic stroke, neural trauma, and heatstroke by inhibiting the activity of M1 phenotype of microglia but augmenting the activity of M2 phenotype of microglia.

Conclusion

This review offers a testable platform for targeting microglial‐mediated cytokines in clinical trials based upon the rational design of MSC therapy in the future. MSCs that are derived from the placenta provide a great choice for stem cell therapy. Although targeting the microglial activation is an important approach to reduce the burden of the injury, it is not the only one. This review focuses on this specific aspect.

Từ khóa


Tài liệu tham khảo

10.1089/neu.2013.3270

10.1002/glia.440070117

10.1002/ana.20501

10.1016/j.brainres.2010.10.063

10.1161/01.STR.28.6.1233

10.1517/13543784.9.10.2281

10.1182/blood.V77.12.2591.2591

10.1097/00004647-200209000-00004

10.1016/j.pneurobio.2005.06.004

10.1097/00001756-200004070-00013

10.1161/01.STR.0000141680.49960.d7

10.1378/chest.104.5.1498

10.1097/WNR.0b013e3283430a44

10.1038/nm0796-788

10.1371/journal.pone.0069515

10.1152/ajpcell.00221.2010

10.1634/stemcells.2007-0197

10.3109/08820139309084183

10.1042/CS20120226

10.1097/01.shk.0000248593.71388.40

10.1097/01.CCM.0000165966.28936.89

10.1016/j.expneurol.2005.11.015

10.2174/1570159X11311020001

10.1161/hs1101.098367

10.1371/journal.pone.0001886

10.3727/096368913X667006

10.1186/s12967-014-0253-7

10.1016/j.brainres.2014.10.065

10.2174/0929867321666141106124657

10.1097/00001756-200009110-00035

10.1186/1742-2094-5-46

10.1016/j.neuroscience.2005.01.031

10.1093/jnen/62.2.127

10.1038/nn1472

10.1016/j.bbi.2009.09.010

10.1080/14653240600760808

10.1080/14653240600855905

10.1056/NEJMra041996

10.1097/00007890-196803000-00009

10.1097/00004647-199812000-00001

10.1038/jcbfm.2014.45

10.1177/154405910208100806

10.3389/fneur.2013.00030

10.1097/01.WCB.0000055177.50448.FA

10.1016/S0006-8993(98)01140-8

10.1007/s10495-014-1020-1

10.1097/CCM.0b013e3181f17c0e

10.1016/j.jtcvs.2007.07.071

10.1254/jphs.FP0071567

10.1089/ten.tea.2011.0385

10.3892/etm.2013.1083

10.1189/jlb.1109766

10.1177/0885066608318458

Kalladka D., 2014, Brain repair: Cell therapy in stroke, Stem Cells Cloning, 7, 31

Kao C. H., 2008, Human umbilical cord blood‐derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors, Shock, 2008, 49, 10.1097/shk.0b013e31805cddce

10.1161/01.RES.0000118601.37875.AC

10.1016/j.pediatrneurol.2008.09.018

10.1073/pnas.96.19.10711

10.1016/j.ymthe.2004.09.020

10.1038/jcbfm.2012.88

10.1523/JNEUROSCI.5505-08.2009

10.1038/sj.jcbfm.9600014

10.1002/stem.430

10.1371/journal.pone.0134920

10.1152/japplphysiol.01040.2005

10.1212/WNL.59.4.514

10.1016/j.brainres.2010.03.080

10.1016/0304-3940(94)90108-2

10.1161/STROKEAHA.110.603621

Lin M. T., 1997, Involvement of interleukin‐1 receptor mechanisms in development of arterial hypotension in rat heatstroke, American Journal of Physiology, 273, H2072

10.1016/S1875-9572(09)60065-6

10.1016/j.expneurol.2004.09.018

10.3727/096020198389924

10.1042/BST0341327

10.2174/1567202611310020003

Mannix R. C., 2012, Traumatic brain injury, microglia, and beta amyloid, International Journal of Alzheimer's Disease, 60872

10.4252/wjsc.v6.i2.82

10.1186/1742-2094-5-45

10.1186/scrt516

10.1016/j.neuroscience.2007.04.035

10.1126/science.1088417

10.1155/2014/539051

10.1016/j.bcp.2014.01.008

10.1186/scrt151

10.3171/spi.2006.5.5.424

10.1073/pnas.252784899

10.1016/S1084-9521(03)00011-9

10.1155/2014/437521

10.1634/stemcells.2007-0637

10.1161/01.STR.0000226980.95389.0b

10.1007/s11481-006-9012-8

10.1172/JCI119808

10.1006/exnr.2000.7389

10.1089/152581603322023007

10.1097/01.brs.0000138273.02820.0a

10.1016/j.neuroscience.2005.08.092

10.1111/j.1365-2990.2008.01005.x

10.3727/096368913X667510

10.1002/stem.1808

10.1073/pnas.0801447105

10.1523/JNEUROSCI.1091-07.2007

10.1007/s40261-014-0186-1

10.1089/neu.2014.3562

10.1155/2014/685683

10.3727/096368914X678580

10.1097/MD.0000000000000813

10.2147/DDDT.S67655

10.1523/JNEUROSCI.22-02-00486.2002

10.1523/JNEUROSCI.1835-10.2010

10.1016/j.bbi.2009.10.017

10.1161/STROKEAHA.111.000326

10.1002/ana.23543

10.1161/01.STR.0000141681.06735.9b

10.1002/jnr.22279

10.1016/j.bbi.2013.12.010

10.1089/scd.2009.0188

10.1016/j.brainres.2013.08.001

10.1634/stemcells.2008-0333

10.1016/j.nbd.2012.03.002

10.1073/pnas.0337659100

10.1634/stemcells.2004-0149

10.1002/jnr.22501

10.1038/jcbfm.2008.68

10.1016/j.ejphar.2011.04.018

10.1097/CCM.0b013e31822629ba

10.3171/2014.11.JNS14770

10.1186/1742-2094-10-106

10.1006/exnr.2001.7853